ReviewMed Oncol2021
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer.
- Journal
- Med Oncol
- Published
- 23 April 2021
- Citations
- 3
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer, being one of the most fatal cancers, is the 7th leading cause of death globally. Cancer that is resistant to current treatment proves that there is a need for personalized and targeted therapy, based on the tumor and genomic markers. … Excerpt only: this text is the publisher’s. Read it in full at the source.